Tiziana Life Sciences Founder Buys 15,000 Shares, Signals Insider Confidence Amid Volatile Shares and Promising MS Pipeline Flash News.
Insider buying of Tiziana Life Sciences shares signals confidence in its intranasal foralumab pipeline, suggesting a potential undervalued long‑term opportunity.
2 minutes to read


